BioStock: Lipum’s work with its Target Product Profile

Developing a so-called Target Product Profile is an important part of the drug development process, especially since it provides an early target and serves as a steering document for planning. A TTP can both reduce development time and costs, as well as attract partners and investors. Lipum is actively working with this for its drug candidate SOL-116 for the treatment of inflammatory diseases. BioStock had the opportunity to talk to Sven Undeland who is involved in this work at Lipum.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/06/lipums-work-with-its-target-product-profile/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se